354 related articles for article (PubMed ID: 31672916)
1. A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.
Steichen JM; Lin YC; Havenar-Daughton C; Pecetta S; Ozorowski G; Willis JR; Toy L; Sok D; Liguori A; Kratochvil S; Torres JL; Kalyuzhniy O; Melzi E; Kulp DW; Raemisch S; Hu X; Bernard SM; Georgeson E; Phelps N; Adachi Y; Kubitz M; Landais E; Umotoy J; Robinson A; Briney B; Wilson IA; Burton DR; Ward AB; Crotty S; Batista FD; Schief WR
Science; 2019 Dec; 366(6470):. PubMed ID: 31672916
[TBL] [Abstract][Full Text] [Related]
2. Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.
Steichen JM; Phung I; Salcedo E; Ozorowski G; Willis JR; Baboo S; Liguori A; Cottrell CA; Torres JL; Madden PJ; Ma KM; Sutton HJ; Lee JH; Kalyuzhniy O; Allen JD; Rodriguez OL; Adachi Y; Mullen TM; Georgeson E; Kubitz M; Burns A; Barman S; Mopuri R; Metz A; Altheide TK; Diedrich JK; Saha S; Shields K; Schultze SE; Smith ML; Schiffner T; Burton DR; Watson CT; Bosinger SE; Crispin M; Yates JR; Paulson JC; Ward AB; Sok D; Crotty S; Schief WR
Science; 2024 May; 384(6697):eadj8321. PubMed ID: 38753769
[TBL] [Abstract][Full Text] [Related]
3. Vaccination induces broadly neutralizing antibody precursors to HIV gp41.
Schiffner T; Phung I; Ray R; Irimia A; Tian M; Swanson O; Lee JH; Lee CD; Marina-Zárate E; Cho SY; Huang J; Ozorowski G; Skog PD; Serra AM; Rantalainen K; Allen JD; Baboo S; Rodriguez OL; Himansu S; Zhou J; Hurtado J; Flynn CT; McKenney K; Havenar-Daughton C; Saha S; Shields K; Schultze S; Smith ML; Liang CH; Toy L; Pecetta S; Lin YC; Willis JR; Sesterhenn F; Kulp DW; Hu X; Cottrell CA; Zhou X; Ruiz J; Wang X; Nair U; Kirsch KH; Cheng HL; Davis J; Kalyuzhniy O; Liguori A; Diedrich JK; Ngo JT; Lewis V; Phelps N; Tingle RD; Spencer S; Georgeson E; Adachi Y; Kubitz M; Eskandarzadeh S; Elsliger MA; Amara RR; Landais E; Briney B; Burton DR; Carnathan DG; Silvestri G; Watson CT; Yates JR; Paulson JC; Crispin M; Grigoryan G; Ward AB; Sok D; Alt FW; Wilson IA; Batista FD; Crotty S; Schief WR
Nat Immunol; 2024 Jun; 25(6):1073-1082. PubMed ID: 38816615
[TBL] [Abstract][Full Text] [Related]
4. Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction.
Wiehe K; Saunders KO; Stalls V; Cain DW; Venkatayogi S; Martin Beem JS; Berry M; Evangelous T; Henderson R; Hora B; Xia SM; Jiang C; Newman A; Bowman C; Lu X; Bryan ME; Bal J; Sanzone A; Chen H; Eaton A; Tomai MA; Fox CB; Tam YK; Barbosa C; Bonsignori M; Muramatsu H; Alam SM; Montefiori DC; Williams WB; Pardi N; Tian M; Weissman D; Alt FW; Acharya P; Haynes BF
Cell Host Microbe; 2024 May; 32(5):693-709.e7. PubMed ID: 38670093
[TBL] [Abstract][Full Text] [Related]
5. Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors.
Willis JR; Berndsen ZT; Ma KM; Steichen JM; Schiffner T; Landais E; Liguori A; Kalyuzhniy O; Allen JD; Baboo S; Omorodion O; Diedrich JK; Hu X; Georgeson E; Phelps N; Eskandarzadeh S; Groschel B; Kubitz M; Adachi Y; Mullin TM; Alavi NB; Falcone S; Himansu S; Carfi A; Wilson IA; Yates JR; Paulson JC; Crispin M; Ward AB; Schief WR
Immunity; 2022 Nov; 55(11):2149-2167.e9. PubMed ID: 36179689
[TBL] [Abstract][Full Text] [Related]
6. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
LaBranche CC; Henderson R; Hsu A; Behrens S; Chen X; Zhou T; Wiehe K; Saunders KO; Alam SM; Bonsignori M; Borgnia MJ; Sattentau QJ; Eaton A; Greene K; Gao H; Liao HX; Williams WB; Peacock J; Tang H; Perez LG; Edwards RJ; Kepler TB; Korber BT; Kwong PD; Mascola JR; Acharya P; Haynes BF; Montefiori DC
PLoS Pathog; 2019 Sep; 15(9):e1008026. PubMed ID: 31527908
[TBL] [Abstract][Full Text] [Related]
7. Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.
Williams WB; Wiehe K; Saunders KO; Haynes BF
J Int AIDS Soc; 2021 Nov; 24 Suppl 7(Suppl 7):e25831. PubMed ID: 34806332
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.
Jardine JG; Kulp DW; Havenar-Daughton C; Sarkar A; Briney B; Sok D; Sesterhenn F; Ereño-Orbea J; Kalyuzhniy O; Deresa I; Hu X; Spencer S; Jones M; Georgeson E; Adachi Y; Kubitz M; deCamp AC; Julien JP; Wilson IA; Burton DR; Crotty S; Schief WR
Science; 2016 Mar; 351(6280):1458-63. PubMed ID: 27013733
[TBL] [Abstract][Full Text] [Related]
9. Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
Beltran-Pavez C; Bontjer I; Gonzalez N; Pernas M; Merino-Mansilla A; Olvera A; Miro JM; Brander C; Alcami J; Sanders RW; Sanchez-Merino V; Yuste E
J Virol; 2022 Jan; 96(1):e0134321. PubMed ID: 34668778
[TBL] [Abstract][Full Text] [Related]
10. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
McGuire AT; Glenn JA; Lippy A; Stamatatos L
J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.
Jardine JG; Ota T; Sok D; Pauthner M; Kulp DW; Kalyuzhniy O; Skog PD; Thinnes TC; Bhullar D; Briney B; Menis S; Jones M; Kubitz M; Spencer S; Adachi Y; Burton DR; Schief WR; Nemazee D
Science; 2015 Jul; 349(6244):156-61. PubMed ID: 26089355
[TBL] [Abstract][Full Text] [Related]
12. HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.
Steichen JM; Kulp DW; Tokatlian T; Escolano A; Dosenovic P; Stanfield RL; McCoy LE; Ozorowski G; Hu X; Kalyuzhniy O; Briney B; Schiffner T; Garces F; Freund NT; Gitlin AD; Menis S; Georgeson E; Kubitz M; Adachi Y; Jones M; Mutafyan AA; Yun DS; Mayer CT; Ward AB; Burton DR; Wilson IA; Irvine DJ; Nussenzweig MC; Schief WR
Immunity; 2016 Sep; 45(3):483-496. PubMed ID: 27617678
[TBL] [Abstract][Full Text] [Related]
13. Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.
Gao F; Bonsignori M; Liao HX; Kumar A; Xia SM; Lu X; Cai F; Hwang KK; Song H; Zhou T; Lynch RM; Alam SM; Moody MA; Ferrari G; Berrong M; Kelsoe G; Shaw GM; Hahn BH; Montefiori DC; Kamanga G; Cohen MS; Hraber P; Kwong PD; Korber BT; Mascola JR; Kepler TB; Haynes BF
Cell; 2014 Jul; 158(3):481-91. PubMed ID: 25065977
[TBL] [Abstract][Full Text] [Related]
14. Targeting broadly neutralizing antibody precursors: a naïve approach to vaccine design.
McGuire AT
Curr Opin HIV AIDS; 2019 Jul; 14(4):294-301. PubMed ID: 30946041
[TBL] [Abstract][Full Text] [Related]
15. Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models.
Tian M; McGovern K; Cheng HL; Waddicor P; Rieble L; Dao M; Chen Y; Kimble MT; Cantor E; Manfredonia N; Judson R; Chapdelaine-Williams A; Cain DW; Haynes BF; Alt FW
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7929-7940. PubMed ID: 32209668
[TBL] [Abstract][Full Text] [Related]
16. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
[TBL] [Abstract][Full Text] [Related]
17. B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.
Huang D; Abbott RK; Havenar-Daughton C; Skog PD; Al-Kolla R; Groschel B; Blane TR; Menis S; Tran JT; Thinnes TC; Volpi SA; Liguori A; Schiffner T; Villegas SM; Kalyuzhniy O; Pintea M; Voss JE; Phelps N; Tingle R; Rodriguez AR; Martin G; Kupryianov S; deCamp A; Schief WR; Nemazee D; Crotty S
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22920-22931. PubMed ID: 32873644
[TBL] [Abstract][Full Text] [Related]
18. Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies.
McGuire AT; Hoot S; Dreyer AM; Lippy A; Stuart A; Cohen KW; Jardine J; Menis S; Scheid JF; West AP; Schief WR; Stamatatos L
J Exp Med; 2013 Apr; 210(4):655-63. PubMed ID: 23530120
[TBL] [Abstract][Full Text] [Related]
19. Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
Madan B; Zhang B; Xu K; Chao CW; O'Dell S; Wolfe JR; Chuang GY; Fahad AS; Geng H; Kong R; Louder MK; Nguyen TD; Rawi R; Schön A; Sheng Z; Nimrania R; Wang Y; Zhou T; Lin BC; Doria-Rose NA; Shapiro L; Kwong PD; DeKosky BJ
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649208
[TBL] [Abstract][Full Text] [Related]
20. Env-2dCD4 S60C complexes act as super immunogens and elicit potent, broadly neutralizing antibodies against clinically relevant human immunodeficiency virus type 1 (HIV-1).
Killick MA; Grant ML; Cerutti NM; Capovilla A; Papathanasopoulos MA
Vaccine; 2015 Nov; 33(46):6298-306. PubMed ID: 26432912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
